CONNECSTAR
"CONNECSTAR" is a word mark owned by Sanofi, filed at the EUIPO on July 6, 2026. It is registered and covers classes 9, 10 and 44.
- Status
- Registered
- Filed
- July 6, 2026
- Registered
- October 18, 2026
- Expires
- July 6, 2036
- Application no.
- 019390968
- Registration no.
- 019390968
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 3 classes
Who owns CONNECSTAR
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Sanofi
Representative
Casalonga Alicante, S.L.
Casalonga Alicante, S.L
What the mark covers
The products and services CONNECSTAR is filed for, grouped by Nice class.
Measuring instruments; Measuring apparatus; Signalling apparatus and instruments; Checking (supervision) apparatus and instruments; Data processing equipment; Computer programs, recorded; Downloadable applications for use with mobile devices; Educational mobile applications; Web application software; Artificial intelligence and machine learning software; Artificial intelligence software for healthcare; Training software; Educational software; Machine learning software for healthcare; Computer software platforms; Computer programs, downloadable; Virtual reality software for medical teaching; Downloadable mobile applications for the management of data; Downloadable mobile applications for the management of information; Health monitoring software; Downloadable computer software for the management of data; Downloadable computer software for remote monitoring and analysis; Computer software applications, downloadable; Downloadable software applications; Computer application software for use with wearable computer devices; Software as a medical device [SaMD], downloadable; Application software for wireless devices; Apparatus for the transmission of data; Sensors, detectors and monitoring equipment; Microprocessor cards; Memory boards; Computer software, recorded
Medical apparatus and instruments; Injection instruments without needles; Injection device for pharmaceuticals; Hypodermic injectors; Inoculating apparatus; Apparatus for drug administration; Apparatus for administering pharmaceuticals; Hypodermic syringes for use in administering injection substances; Automatic medical apparatus for dosing humans by injection; Automatic medical apparatus for dosing animals by injection; Implantable subcutaneous drug delivery devices; Autoinjectors for the administration of pharmaceutical preparations; Dosage dispensers for medical use; Syringes in the nature of pens; Injectors for medical purposes; Medication injectors; Diabetic monitoring apparatus; Medical diagnostic, examination, and monitoring equipment; Medical test kits for diabetes monitoring for home use; Medical instruments for therapeutic drug monitoring; Medical instruments for recording physiological data
Medical services; Medical services in the field of treatment of chronic pain; Providing medical information; Telemedicine services; Providing information to patients in the field of administering medications; Providing information relating to medical services; Providing information via the Internet in the field of diabetes; Providing medical support in the monitoring of patients receiving medical treatments; Medical services in the field of diabetes; Individual medical counseling services provided to patients; Medical care and analysis services relating to patient treatment; Medical information services provided via the Internet; Medical information retrieval services; Consultancy and information services relating to medical products; Remote monitoring of medical data for medical diagnosis and treatment; Monitoring of patients; Providing online medical record services other than dentistry; Medical diagnostic services; Pathological testing for diagnostic and treatment purposes; Medical tele-reporting [medical services]; Medical services for the diagnosis of conditions of the human body
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2026/128 Section A.1
About CONNECSTAR
Who owns the trademark "CONNECSTAR"?
The EUIPO trademark "CONNECSTAR" (application 019390968) is owned by Sanofi.
What is the status of "CONNECSTAR"?
Its status at the EUIPO is: registered.
When was "CONNECSTAR" registered?
It was registered on October 18, 2026 and is due to expire on July 6, 2036.
Get this data via the API
Everything on this page comes from the Signa API. Pull CONNECSTAR and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019f3b64-010f-7166-94bf-f79b95c3e4e9
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019f3b64-010f-7166-94bf-f79b95c3e4e9",
"object": "trademark",
"mark_text": "CONNECSTAR",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "019390968",
"filing_date": "2026-07-06",
"nice_classes": [
9,
10,
44
],
"owners": [
{
"name": "SANOFI",
"entity_id": "ent_019eb6f6-62f9-773d-a835-46d137e82556"
}
]
}